CONMED Corp (CNMD) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-04-29

Key Insights

CONMED released Q1 2026 earnings results on April 29, 2026, indicating routine quarterly financial reporting with no material transactions, acquisitions, or leadership changes disclosed.
Andrew Moller is identified as Interim Principal Financial Officer and VP, Corporate Controller, suggesting a potential temporary CFO arrangement that warrants monitoring for permanent appointment announcements.
The 8-K filing contains minimal disclosure beyond earnings announcement, with actual financial results relegated to the press release exhibit, indicating this is a standard quarterly earnings report without material events.

Want the newest filings?

This analysis covers the filing from 2026-04-29. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-03-13

CONMED Corporation appointed Andrew Moller as Interim Principal Financial Officer, effective March 15, 2026. Moller has extensive financial leadership experience at Smith & Nephew and Stanley Black & Decker.
There were no changes to Moller's compensation arrangements in connection with his appointment as Interim Principal Financial Officer.
There are no related-party transactions or family relationships between Moller and the members of CONMED's Board of Directors that require disclosure.

Filed: 2026-01-28

CONMED Corporation reported fourth quarter 2025 financial results, indicating the company's performance for the full year.
The company did not provide any forward-looking guidance or commentary on the current business environment in the press release.
Without additional details on the company's financial performance or strategic initiatives, there are limited insights that can be gleaned from this routine earnings release.

Filed: 2026-01-12

CONMED Corporation provided preliminary financial guidance for 2026, indicating potential growth and performance for the upcoming year.
The company plans to present the investor presentation at the upcoming J.P. Morgan Healthcare Conference, which could signal important strategic updates or developments for investors to consider.
The filing does not mention any material agreements, leadership changes, or earnings surprises, suggesting a routine update rather than a significant event.

Filed: 2026-01-08

CONMED Corporation announced the separation of its Chief Financial Officer, Todd Garner, effective March 15, 2026 or the date a new CFO is appointed.
The company has retained an executive search firm to find a permanent replacement for the CFO role, indicating a planned leadership transition.
During the transition period, Garner will continue to receive his current compensation and benefits, and his outstanding equity awards will continue to vest through November 2026.

Other reports for CONMED Corp

Quarterly Report Insider Trading Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.